Hoxworth celebrates March with exclusive gift for donors
Hoxworth Blood Center is celebrating the month of March with exclusive 3-in-1 tumbler/koozies for all donors.
Donors who roll up a sleeve at a Hoxworth Neighborhood Donor Center March 4-25 will receive an exclusive 3-in-1 tumbler that fits bottles, cans, and beverages.
“As the only steward of the local blood supply, Hoxworth needs at least 450 individuals to donate blood every day to support local patients,” said Alecia Lipton, director of public relations at Hoxworth Blood Center. “This March, we’re inviting all eligible donors to roll up a sleeve and share their wealth of good health to someone in need in our community.”
Hoxworth serves over 30 hospitals in the Tri-State area, according to Lipton, and donors are always needed — because “it’s the blood that is on the shelf that will be used to save lives in an emergency.”
To schedule a donation, call Hoxworth at 513-451-0910 or visit www.hoxworth.org. Appointments are encouraged to maintain proper social distancing, and masks are required of all donors.
About Hoxworth:
Hoxworth Blood Center, University of Cincinnati, was founded in 1938, and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.